ScholarX: Browsing ScholarWorks

Browsing by Triantos, S[Triantos, Spyros]Author

All A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

전체 가 나 다 라 마 바 사 아 자 차 카 타 파 하

Sort by: In order: Results/Page Authors/Record:

Showing results 1 to 2 of 2

SCIESCOPUS

Phase 3 THOR study: Results of erdafitinib (erda) versus chemotherapy (chemo) in patients (pts) with advanced or metastatic urothelial cancer (mUC) with select fibroblast growth factor receptor alterations (FGFRalt)

Loriot, Y[Loriot, Yohann]; Matsubara, N[Matsubara, Nobuaki]; Park, SH[Park, Se Hoon]; Huddart, RA[Huddart, Robert A.]; Burgess, EF[Burgess, Earle F.]; Houede, N[Houede, Nadine]; Banek, S[Banek, Severine]; Laguerre, B[Laguerre, Brigitte]; Guadalupi, V[Guadalupi, Valentina]; Ku, JH[Ku, Ja Hyeon], et al.

ArticleIssue Date2023CitationJOURNAL OF CLINICAL ONCOLOGY, v.41, no.17PublisherLIPPINCOTT WILLIAMS & WILKINS

SCIESCOPUS

Updated analysis with longer follow up of a phase 2a study evaluating erdafitinib in Asian patients (pts) with advanced cholangiocarcinoma (CCA) and fibroblast growth factor receptor (FGFR) alterations

Feng, YH[Feng, Yin-Hsun]; Su, WC[Su, Wu-Chou]; Oh, DY[Oh, Do-Youn]; Shen, L[Shen, Lin]; Kim, KP[Kim, Kyu-Pyo]; Liu, XF[Liu, Xiufeng]; Liao, HM[Liao, Huimin]; Qing, M[Qing, Min]; Qian, JQ[Qian, Jiaqi]; Triantos, S[Triantos, Spyros], et al.

ArticleIssue Date2022CitationJOURNAL OF CLINICAL ONCOLOGY, v.40, no.4PublisherLIPPINCOTT WILLIAMS & WILKINS

STATISTICS: Total View:; Daily View:

RSS_1.0 RSS_2.0 ATOM_1.0

(03063) 25-2, SUNGKYUNKWAN-RO, JONGNO-GU, SEOUL, KOREA samsunglib@skku.edu

Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.

Browsing by Triantos, S[Triantos, Spyros]Author

BROWSE